HBLYX | MRMAX | HBLYX / MRMAX | |
Total Expense Ratio | 0.67 | 1.09 | 61% |
Annual Report Gross Expense Ratio | 0.67 | 1.09 | 61% |
Fund Existence | 19 years | 14 years | - |
Gain YTD | -0.828 | -2.137 | 39% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 250000 | 1000 | 25,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 11.5B | 169M | 6,805% |
Annual Yield % from dividends | 3.53 | 2.77 | 127% |
Returns for 1 year | 0.83 | 1.70 | 49% |
Returns for 3 years | 1.57 | -2.04 | -77% |
Returns for 5 years | 24.98 | 18.01 | 139% |
Returns for 10 years | 32.03 | 7.59 | 422% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BMEZ | 13.61 | -0.70 | -4.89% |
BlackRock Health Sciences Term Trust | |||
IBUY | 54.22 | -2.95 | -5.16% |
Amplify Online Retail ETF | |||
XUSP | 33.76 | -2.06 | -5.74% |
Innovator Uncapped Accelerated US Eq ETF | |||
DWAT | 10.51 | -0.64 | -5.74% |
Arrow DWA Tactical Macro ETF | |||
CVLC | 62.46 | -3.91 | -5.89% |
Calvert US Large-Cp Cor Rspnb ETF |